Management Strategy for Patients with Severe AS - Flowchart
Management Strategy for Patients with Severe AS - Flowchart Aortic Stenosis Aortic Stenosis
«Flowchart»

Abnormal aortic valve with reduced systolic opening

Abnormal aortic valve with reduced systolic opening

Abnormal aortic valve with reduced systolic opening

Abnormal aortic valve with reduced systolic opening

Symptoms due to AS

Symptoms due to AS

Symptoms due to AS

No AS symptoms

No AS symptoms

No AS symptoms

End

End

End

AVR (SAVR or TAVI, see section 3.2.4.2)
(1)

AVR (SAVR or TAVI, see section 3.2.4.2)
(1)

AVR (SAVR or TAVI, see section 3.2.4.2)
(1)


Severe AS stage D1


Vmax 4 m/s or
Pmean40 mm Hg

Severe AS stage D1

Severe AS stage D1


Vmax 4 m/s or
Pmean40 mm Hg


Vmax 4 m/s or max
Pmean40 mm Hg mean Severe AS stage D1

Vmax <4 m/s and AVA 1.0 cm2

Vmax <4 m/s and AVA 1.0 cm2

max 2 V(max) <4 m/s

Severe AS stage D3
AVAi0.6 cm2/m2 and SVI <35 mL/m2

Severe AS stage D3
AVAi0.6 cm2/m2 and SVI <35 mL/m2

Severe AS stage D3
AVAi0.6 cm2/m2 and SVI <35 mL/m2

Severe AS stage D3
i 2 2 2

Severe AS stage D2

DSE Vmax 4 m/s at any flow rate

Severe AS stage D2

DSE Vmax 4 m/s at any flow rate

Severe AS stage D2

Severe AS stage D2

DSE Vmax 4 m/s at any flow rate

max

LVEF <50%

LVEF <50%

LVEF <50%

Yes

Yes

Yes Yes

No

No

No No

AS most likely cause of symptoms

AS most likely cause of symptoms

AS most likely cause of symptoms

Other cardiac surgery

Other cardiac surgery

Other cardiac surgery

AS stage C (Vmax 4 m/s)

AS stage C (Vmax 4 m/s)

AS stage C max AS stage C

AS stage B
Vmax 3–3.9 m/s

AS stage B
Vmax 3–3.9 m/s

AS stage B
max AS stage B

SAVR
(2b)

SAVR
(2b)

SAVR
(2b)


AVR (SAVR or TAVI, see section 3.2.4.2) (1)

AVR (SAVR or TAVI, see section 3.2.4.2) (1)

AVR (SAVR or TAVI, see section 3.2.4.2) (1)

SAVR
(2a)

SAVR
(2a)

SAVR
(2a)


LVEF <50%

LVEF <50%

LVEF <50%

Other cardiac surgery

Other cardiac surgery

Other cardiac surgery

ETT with BP or ex. capacity

ETT with BP or ex. capacity

ETT with BP or ex. capacity

Vmax 5 m/s
OR
BNP >3x normal
OR
Rapid disease progression

Vmax 5 m/s
OR
BNP >3x normal
OR
Rapid disease progression


OR

OR
Vmax >=5 m/s

LVEF to <60% on 3 serial studies

LVEF to <60% on 3 serial studies

LVEF to <60% on 3 serial studies